The Enterprise Value as of December 2025 (TTM) for ADC Therapeutics S.A. (ADCT) is 262.56M

According to ADC Therapeutics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 262.56M. This represents a change of 60.85% compared to the average of 163.23M of the last 4 quarters.

ADC Therapeutics S.A. (ADCT) Historical Enterprise Value (quarterly & annually)

How has ADCT Enterprise Value performed in the past?

The mean historical Enterprise Value of ADC Therapeutics S.A. over the last ten years is 854.22M. The current 262.56M Enterprise Value has changed 2.97% with respect to the historical average. Over the past ten years (40 quarters), ADCT's Enterprise Value was at its highest in in the June 2020 quarter at 2.63B. The Enterprise Value was at its lowest in in the September 2023 quarter at -113093608.24.

ADC Therapeutics S.A. (ADCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ADC Therapeutics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ADC Therapeutics S.A. (ADCT) Average Enterprise Value

How has ADCT Enterprise Value performed in the past?

The current Enterprise Value of ADC Therapeutics S.A. (ADCT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ADC Therapeutics S.A. (ADCT) Enterprise Value vs. Peers

How is ADCT’s Enterprise Value compared to its peers?

ADC Therapeutics S.A.’s Enterprise Value is less than Omeros Corporation (883.69M), greater than Neumora Therapeutics, Inc. Common Stock (251.41M), less than RAPT Therapeutics, Inc. (534.71M), less than Autolus Therapeutics plc (358.55M), less than Alumis Inc. Common Stock (839.07M), greater than Bicycle Therapeutics plc (-152624053.00), less than Lexicon Pharmaceuticals, Inc. (556.11M), less than 4D Molecular Therapeutics, Inc. (496.31M), less than Lineage Cell Therapeutics, Inc. (362.42M), less than Quantum-Si incorporated (276.42M),

Build a custom stock screener for ADC Therapeutics S.A. (ADCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADC Therapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ADC Therapeutics S.A. (ADCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ADC Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.